Elekta AB (publ) (EKTAY)
OTCMKTS · Delayed Price · Currency is USD
5.25
+0.05 (0.87%)
Sep 17, 2025, 3:53 PM EDT
Elekta AB Market Cap
Elekta AB has a market cap or net worth of $2.04 billion as of September 17, 2025. Its market cap has decreased by -20.92% in one year.
Market Cap
2.04B
Enterprise Value
2.59B
Revenue
1.83B
Ranking
n/a
PE Ratio
72.88
Stock Price
$5.25
Market Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 191.46M to 2.04B, an increase of 967.46%. That is a compound annual growth rate of 8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.04B | -3.39% |
| Dec 30, 2024 | 2.12B | -32.17% |
| Dec 29, 2023 | 3.12B | 35.48% |
| Dec 30, 2022 | 2.30B | -52.43% |
| Dec 30, 2021 | 4.84B | -6.05% |
| Dec 30, 2020 | 5.15B | 1.85% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |